Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,603 public trials 2,148 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, Not Recruiting

A First-in-human Study to Learn How Safe the Study Drug BAY2965501 is, Find the Best Dose (Single Drug & Combination), How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, How it Acts on Different Tumors in Participants With Advanced Solid Tumors

NCT05614102

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +31 more
Locations
  • Sarah Cannon Research Institute at HCA HealthONE Presbyterian St. Luke's Denver, Colorado, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • START | San Antonio San Antonio, Texas, United States
  • Antwerp University Hospital | Oncology Department Antwerp, Belgium
View all 21 locations
View Trial Details
Active, Not Recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +42 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Omaha, Nebraska, United States
  • Research Site Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

NCT03528694

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • Research Site Auchenflower, Australia
  • Research Site Box Hill, Australia
  • Research Site Brisbane, Australia
  • Research Site Kogarah, Australia
View all 120 locations
View Trial Details
Active, Not Recruiting

A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent High-Risk Non-Muscle-Invasive Bladder Cancer (HR-NMIBC) After Bacillus Calmette-Guérin (BCG)

NCT06211764

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Arkansas Urology Little Rock, Arkansas, United States
  • Genesis Research LLC 1 Los Alamitos, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Irvine Medical Center Orange, California, United States
View all 123 locations
View Trial Details
Active, Not Recruiting

A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC)

NCT05714202

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • Arkansas Urology Little Rock, Arkansas, United States
  • VA Long Beach Health Care System Long Beach, California, United States
  • Genesis Research, LLC - West Coast Urology Los Alamitos, California, United States
View all 240 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease

NCT04020055

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +32 more
Locations
  • Emory University Atlanta, Georgia, United States
  • The Cleveland Clinic Cleveland, Ohio, United States
  • Lysosomal and Rare Disorders Research and Treatment Center, Inc Fairfax, Virginia, United States
  • Royal Melbourne Hospital Parkville, Victoria, Australia
View Trial Details
Active, Not Recruiting

Post-Market Clinical Follow-Up onTVT EXACT® Continence System

NCT04829994

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Lower Urinary Tract Symptoms, +10 more
Locations
  • Duke University Durham, North Carolina, United States
  • Institute for Female Pelvic Medicine North Wales, Pennsylvania, United States
  • UPMC Pittsburgh, Pennsylvania, United States
  • Ordensklinikum Linz Linz, Austria
View Trial Details

Related conditions